Moderna Inc
(MIL:1MRNA)
€
38.165
-0.445 (-1.15%)
Market Cap: 14.61 Bil
Enterprise Value: 9.32 Bil
PE Ratio: 0
PB Ratio: 1.30
GF Score: 44/100 Moderna Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 03, 2021 / 02:00PM GMT
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst
Well, thank you, and good morning, and welcome to another great session here at the Jefferies Global Healthcare Conference. Obviously, very pleased to have with us here the CEO of Moderna, Stephane Bancel. Thank you for joining with us. I know it's crazy and busy times for you but certainly exciting times and certainly a lot to talk about. So thanks for being here with us.
Stephane Bancel
Moderna, Inc. - CEO & Director
Thank you, Michael, for having me.
Questions & Answers
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst
Let me just start first by talking -- asking you about your perspective on the 2021 outlook for COVID vaccines for Moderna and bridge that into your thoughts and visibility into 2022. This seems to be a big debate, but I'd love to hear your perspective as how that evolves.
Stephane Bancel
Moderna, Inc. - CEO & Director
Sure. So '21, from a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot